Back

Is there a place for beta- 2 microglobulin for prediction and diagnosis of acute kidney injury (AKI) after trancatheter (TAVR) and surgical valve replacement (SAVR)?

16 October 2016 (14:00 - 17:30)
Organised by:
Congress Presentation Part of: Poster Session 4 - Valvular heart disease Valvular heart disease ACVC Premium Access Acute Cardiovascular Care 2016

About the speaker

Photo
Professor Janina Stepinska

National Institute of Cardiology in Anin, Warsaw (Poland)

4 More presentations in this session

Presentation thumbnail
Professor R. Hammami (Sfax, TN)
Abstract Slides
Presentation thumbnail
Mr P. Poustis (Talence, FR)
Abstract
Presentation thumbnail
Doctor H. Nascimento (Santa Maria da Feira, PT)
Abstract
Presentation thumbnail
Doctor O. Mytrokhina (Dnipro, UA)

Access the full session

Session thumbnail
Poster Session 4 - Valvular heart disease

The Event

Event poster

Acute Cardiovascular Care 2016

16 October 2016 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Evaluation of renal tubulointerstitial damage as a residual renal risk factor for adverse cardiac events in patients with aortic valve stenosis
31 August 2024
thumbnail
Congress Presentation
Acute kidney injury as a predictor of bleeding in ACS patients
29 June 2021
thumbnail
Congress Presentation
C-Reactive Protein to Albumin Ratio offers superior risk prediction in patients undergoing mitral valve edge-to-edge repair: a comparison to established surgical risk scores
28 August 2022
thumbnail
Congress Presentation
Clinical outcomes of patients undergoing percutaneous coronary intervention and transcatheter aortic valve implantation versus coronary artery bypass grafting and surgical aortic valve replacement
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources